109 results
Page 3 of 6
8-K
EX-99.2
4rith2
10 Feb 21
Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
9:03am
S-8
knd559t6
19 Jan 21
Registration of securities for employees
12:00am
8-K
EX-99.1
shvj97n
22 Dec 20
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for COVID-19
8:34am
8-K
EX-99.1
1igoga8fq1vlmk
2 Dec 20
Other Events
8:12am
424B4
v2xmsm
25 Nov 20
Prospectus supplement with pricing info
4:28pm
8-K
EX-99.1
5eus32ubck51c07sf3o
5 Oct 20
Announces Creation of Clinical Pharmacology Analytics Team
9:06am
8-K
EX-99.1
davxr
7 Jul 20
Hepion Pharmaceuticals Announces Preclinical Data Supporting Novel Two-Pronged Approach to Treating COVID-19 with CRV431
8:26am
8-K
EX-99.1
03akchy
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-99.1
cqohg8rwnr5s4q7dj
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm
424B4
mxtmykb5b1p7afy
19 Jun 19
Prospectus supplement with pricing info
5:25pm